Vycor Medical (VYCO) Asset Writedowns and Impairment (2018 - 2026)

Vycor Medical (VYCO) has 7 years of Asset Writedowns and Impairment data on file, last reported at $8340.0 in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $8340.0 in Q1 2026; TTM through Mar 2026 was $6850.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2690.0, down 20.3% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $8340.0, up from -$1490.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for VYCO reached as high as $8340.0 in Q1 2026 and fell as low as -$1490.0 in Q3 2024.
• Historically, Asset Writedowns and Impairment has averaged $3890.0 across 3 years, with a median of $4155.0 in 2022.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 92.88% in 2022 and fell as far as 12.62% in 2022.
• Year by year, Asset Writedowns and Impairment stood at $4155.0 in 2022, then sank by 135.86% to -$1490.0 in 2024, then surged by 659.73% to $8340.0 in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $8340.0 in Q1 2026, -$1490.0 in Q3 2024, and $4865.0 in Q1 2024.